John L Lamattina - Net Worth and Insider Trading
John L Lamattina Net Worth
The estimated net worth of John L Lamattina is at least $15 Million dollars as of 2024-11-13. John L Lamattina is the Senior Vice President of Pfizer Inc and owns about 429,454 shares of Pfizer Inc (PFE) stock worth over $11 Million. John L Lamattina is the Director of Ligand Pharmaceuticals Inc and owns about 25,398 shares of Ligand Pharmaceuticals Inc (LGND) stock worth over $3 Million. John L Lamattina is also the Director of Immunome Inc and owns about 51,828 shares of Immunome Inc (IMNM) stock worth over $647,332. Details can be seen in John L Lamattina's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John L Lamattina has not made any transactions after 2021-11-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John L Lamattina
John L Lamattina Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John L Lamattina owns 5 companies in total, including Immunome Inc (IMNM) , Ligand Pharmaceuticals Inc (LGND) , and Larimar Therapeutics Inc (LRMR) among others .
Click here to see the complete history of John L Lamattina’s form 4 insider trades.
Insider Ownership Summary of John L Lamattina
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
IMNM | Immunome Inc | 2021-05-24 | director |
LGND | Ligand Pharmaceuticals Inc | 2021-11-16 | director |
LRMR | Larimar Therapeutics Inc | 2015-07-13 | director |
2007-06-15 | Senior Vice President | ||
2004-03-09 | director |
John L Lamattina Latest Holdings Summary
John L Lamattina currently owns a total of 3 stocks. Among these stocks, John L Lamattina owns 429,454 shares of Pfizer Inc (PFE) as of June 15, 2007, with a value of $11 Million and a weighting of 75.18%. John L Lamattina owns 25,398 shares of Ligand Pharmaceuticals Inc (LGND) as of November 16, 2021, with a value of $3 Million and a weighting of 20.5%. John L Lamattina also owns 51,828 shares of Immunome Inc (IMNM) as of May 24, 2021, with a value of $647,332 and a weighting of 4.33%.
Latest Holdings of John L Lamattina
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
PFE | Pfizer Inc | 2007-06-15 | 429,454 | 26.19 | 11,247,400 |
LGND | Ligand Pharmaceuticals Inc | 2021-11-16 | 25,398 | 120.74 | 3,066,555 |
IMNM | Immunome Inc | 2021-05-24 | 51,828 | 12.49 | 647,332 |
Holding Weightings of John L Lamattina
John L Lamattina Form 4 Trading Tracker
According to the SEC Form 4 filings, John L Lamattina has made a total of 0 transactions in Pfizer Inc (PFE) over the past 5 years. The most-recent trade in Pfizer Inc is the sale of 36,066 shares on June 15, 2007, which brought John L Lamattina around $955,028.
According to the SEC Form 4 filings, John L Lamattina has made a total of 1 transactions in Ligand Pharmaceuticals Inc (LGND) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Ligand Pharmaceuticals Inc is the sale of 4,835 shares on November 16, 2021, which brought John L Lamattina around $782,593.
According to the SEC Form 4 filings, John L Lamattina has made a total of 1 transactions in Immunome Inc (IMNM) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Immunome Inc is the acquisition of 5,440 shares on May 24, 2021, which cost John L Lamattina around $101,021.
Insider Trading History of John L Lamattina
- 1
John L Lamattina Trading Performance
GuruFocus tracks the stock performance after each of John L Lamattina's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John L Lamattina is -12.09%. GuruFocus also compares John L Lamattina's trading performance to market benchmark return within the same time period. The performance of stocks bought by John L Lamattina within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John L Lamattina's insider trading performs compared to the benchmark.
Performance of John L Lamattina
John L Lamattina Ownership Network
Ownership Network List of John L Lamattina
Ownership Network Relation of John L Lamattina
John L Lamattina Owned Company Details
What does Immunome Inc do?
Who are the key executives at Immunome Inc?
John L Lamattina is the director of Immunome Inc. Other key executives at Immunome Inc include SVP Operations Max Rosett , Chief Scientific Officer Jack Higgins , and director & President and CEO Clay B Siegall .
Immunome Inc (IMNM) Insider Trades Summary
Over the past 18 months, John L Lamattina made no insider transaction in Immunome Inc (IMNM). Other recent insider transactions involving Immunome Inc (IMNM) include a net purchase of 269,204 shares made by Clay B Siegall , a net purchase of 9,000 shares made by Jean Jacques Bienaime , and a net purchase of 42,300 shares made by Bruce Turner .
In summary, during the past 3 months, insiders sold 17,904 shares of Immunome Inc (IMNM) in total and bought 7,000 shares, with a net sale of 10,904 shares. During the past 18 months, 17,904 shares of Immunome Inc (IMNM) were sold and 320,504 shares were bought by its insiders, resulting in a net purchase of 302,600 shares.
Immunome Inc (IMNM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Immunome Inc Insider Transactions
John L Lamattina Mailing Address
Above is the net worth, insider trading, and ownership report for John L Lamattina. You might contact John L Lamattina via mailing address: 81 Wyman St, Post Office Box 9046, Waltham Ma 02454.